Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
SEC Accession No. 0000897204-18-000030
Filing Date
2018-04-12
Accepted
2018-04-12 11:29:58
Documents
1

Document Format Files

Seq Description Document Type Size
1 GENEXTRA SCHEDULE 13G/A schedule13ga.htm SC 13G/A 49761
  Complete submission text file 0000897204-18-000030.txt   51225
Mailing Address 450 W. 15TH STREET SUITE 505 New York NY 10011
Business Address 450 W. 15TH STREET SUITE 505 NEW YORK NY 10011 646-747-1000
INTERCEPT PHARMACEUTICALS INC (Subject) CIK: 0001270073 (see all company filings)

IRS No.: 223868459 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G/A | Act: 34 | File No.: 005-87033 | Film No.: 18751494
SIC: 2834 Pharmaceutical Preparations

Mailing Address VIA G. DE GRASSI, 11 MILAN L6 20123
Business Address VIA G. DE GRASSI, 11 MILAN L6 20123 390236515110
Genextra S.p.A. (Filed by) CIK: 0001559515 (see all company filings)

IRS No.: 000000000 | State of Incorp.: L6 | Fiscal Year End: 1212
Type: SC 13G/A